knowledge -WSS

knowledge

author：entertainment 2025-09-03 11:51:26 - browse：44176

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Doudna institute plans to 'cure hundreds of diseases' with CRISPR

WSS

Generative AI mines health records to identify patients’ social needs

Attacks on the drug industry will lead to fewer breakthroughs

The nurse manager staffing crisis is hurting patients

JPM 2024: Nvidia claims we're in biological revolution. Are we?

What the cancer research community can learn from the Covid response

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Tori Bowie and the unacceptable rates of Black maternal death

New England Journal of Medicine addresses racist history, slavery

Activists slam private health insurers over coverage restrictions

Dramatically reducing cancer deaths requires the PASTEUR Act

How to save PrEP access — and even expand it

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

In age of alternative facts, a scholarly course on calling out crap

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Psychedelics group wrestles with new pharma identity

As JPM 2024 winds down, some health tech firms project optimism

Wikipedia

Health and fitness trackers are measuring the wrong things

Heart disease and mental health: A look at cardiac psychology

Biden calls for immediate release of Niger's president amid apparent coup

Doulas covered by Medicaid under New York's new plan

Risky weight loss products often used by teens globally, per study

How I ended up pumping milk in a bathroom stall at JPM 2024

explore

focus

entertainment

leisure time